|
Status |
Public on Jun 29, 2016 |
Title |
Cira29 |
Sample type |
genomic |
|
|
Source name |
human induced pluripotent stem cells
|
Organism |
Homo sapiens |
Characteristics |
cell type: human induced pluripotent stem cells
|
Growth protocol |
Human pluripotent stem cells were culture on mitomycin C-treated SNL feeder cells in Primate ES cell medium (ReproCELL) containing 4 ng/mL recombinant bFGF (Wako)
|
Extracted molecule |
genomic DNA |
Extraction protocol |
GenomicDNA lysates were extracted with DNeasy(R) blood and tissue kit (QIAgen) in accordance with manufacture's protocol.
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
Standard Illumina protocol
|
Scan protocol |
Standard recommended Illumina scanner setting protocol using BeadArray Reader
|
Description |
human induced pluripotent stem cells derived from peripheral blood SAMPLE 15
|
Data processing |
Illumina GenomeStudio software and GeneSpring (Agilent Techonologies) Unmethylated(Signal_A) and methylated(Signal_B) signal intensities
|
|
|
Submission date |
Aug 27, 2014 |
Last update date |
Jun 29, 2016 |
Contact name |
Yoshinori Yoshida |
E-mail(s) |
yoshinor@cira.kyoto-u.ac.jp
|
Organization name |
Kyoto University
|
Street address |
53, Kawahara-cho, Shogoin, Sakyo-ku
|
City |
Kyoto |
ZIP/Postal code |
6068507 |
Country |
Japan |
|
|
Platform ID |
GPL13534 |
Series (2) |
GSE60821 |
Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells [undiff_iPSESCs_methylation] |
GSE60924 |
Reprogramming-associated aberrant DNA methylation determines hematopoietic differentiation capacity of human induced pluripotent stem cells |
|